» Articles » PMID: 23200590

[A Multi-centre Randomized Controlled Trial of Domiciliary Non-invasive Ventilation Vs Long-term Oxygen Therapy in Survivors of Acute Hypercapnic Respiratory Failure Due to COPD. Non-invasive Ventilation in Obstructive Lung Disease (NIVOLD) Study]

Overview
Journal Rev Mal Respir
Specialty Pulmonary Medicine
Date 2012 Dec 4
PMID 23200590
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Patients with chronic hypercapnic respiratory failure due to chronic obstructive pulmonary disease (COPD) are very likely to develop acute exacerbations. Non-invasive ventilation is often used to treat acute respiratory failure but little information is available about the benefits of domiciliary non-invasive ventilation in COPD patients with chronic hypercapnic respiratory failure who survive an acute episode. The purpose of this study is to determine whether domiciliary non-invasive ventilation can reduce the incidence of recurrent acute hypercapnic respiratory failure in COPD patients who survived an episode of acute hypercapnic respiratory failure (AHRF).

Methods: A multi-center randomized controlled trial including patients with COPD who survived an episode of AHRF. Patients will be randomly assigned to receive long-term oxygen therapy (LTOT) (no intervention) or domiciliary non-invasive ventilation (active comparator) in addition to LTOT. In France, three university hospitals: Rouen, Caen and Amiens and three general hospitals: Dieppe, Le Havre and Elbeuf are recruiting.

Inclusion Criteria: Age above 18 years; patients with COPD who have survived an episode of AHRF; patients weaned from non-invasive or mechanical ventilation for at least seven days following an acute episode; with stable arterial blood gases for at least two days: PaCO(2) greater than 55mmHg and pH greater than 7.35. Exclusion criteria are: age above 85 years, other causes of respiratory failure, obstructive sleep apnoea, adverse psychosocial status, serious co-morbidity. Primary outcome is the frequency of episodes of acute hypercapnic respiratory failure (time frame: up to 102 weeks), secondary outcome is mortality (time frame: 1 month and every 6 months for 2 years).

Expected Results: A decreased rate of episodes of acute hypercapnic respiratory failure in the group of patients receiving non-invasive ventilation in addition to long term oxygen therapy.

Citing Articles

Chronic non-invasive ventilation for chronic obstructive pulmonary disease.

Raveling T, Vonk J, Struik F, Goldstein R, Kerstjens H, Wijkstra P Cochrane Database Syst Rev. 2021; 8:CD002878.

PMID: 34368950 PMC: 8407093. DOI: 10.1002/14651858.CD002878.pub3.


An official American Thoracic Society/European Respiratory Society statement: research questions in COPD.

Celli B, Decramer M, Wedzicha J, Wilson K, Agusti A, Criner G Eur Respir Rev. 2015; 24(136):159-72.

PMID: 26028628 PMC: 9487818. DOI: 10.1183/16000617.00000315.


Predicting survival after acute exacerbation chronic obstructive pulmonary disease (ACOPD): is long-term application of noninvasive ventilation the last life guard?.

Esquinas A, Matsuoka Y, Stieglitz S Int J Chron Obstruct Pulmon Dis. 2013; 8:379-81.

PMID: 24009417 PMC: 3760763. DOI: 10.2147/COPD.S49455.